Youzhen Xiong

Featured in: Favicon

Articles

Hetrombopag Plus Porcine ATG and Cyclosporine for the Treatment of Aplastic Anaemia: Early Outcomes of a Prospective Pilot Study

Aug 29, 2024 | digitalcommons.library.tmc.edu | Wenrui Yang |Xin Zhao |Xu Liu |Youzhen Xiong

Hetrombopag, a small molecular thrombopoietin-receptor agonist, has shown encouraging efficiency in immunosuppressive therapy refractory or relapsed severe aplastic anaemia. To investigate the response rate of hetrombopag combined with IST as first-line treatment, we designed a prospective pilot study including 32 patients with SAA treated with anti-human T lymphocyte porcine immunoglobulin (p-ATG), cyclosporine, and hetrombopag.

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.